Medtronic plc vs Eli Lilly & Co.
MDT vs LLY — side-by-side comparison from reported financials. MDT leads 3, LLY leads 7 of 10 comparable metrics.
Medtronic plc
MDT · Healthcare
$88.01+0.30%Mixed
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | MDT | LLY |
|---|---|---|
| Price | $88.01 | $1 177.20 |
| Market cap | $113B | $1.05T |
| Revenue (TTM) | $37.5B | $79.7B |
| Revenue growth | +5.2% | +31.7% |
| Net margin | 13.9% | 33.5% |
| Free cash flow | $6.13B | $18.2B |
| Net cash (debt) | — | ($35.2B) |
| 1-year price return | -8.8% | +37.6% |
| P/E | 21.6 | 41.6 |
| P/E vs own history (cheap-side %) | 96% | 88% |
| Dividend yield | 3.22% | 0.52% |
| Return on equity | 11% | 93% |
| Altman Z-score | — | 7.10 |
| CV checks passed | 10 of 11 | 11 of 11 |
| Employees | 95,000 | 50,000 |
Full résumé-style profiles: MDT CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.